Breakthrough in making swine flu vaccines
Friday, 4 September 2009
Breakthrough in making swine flu vaccines
BASEL (Switzerland), Sept 3 (AFP): Swiss pharmaceutical giant Novatis said Thursday it had tested a new swine flu vaccine that may require only one dose while China also unveiled a one-dose drug designed to curb the pandemic.
Novatis said it was ready to produce one million doses of the vaccine before the end of the year in a bid to blunt the spread of swine flu that has already claimed at least 2,185 lives including its first victim in Norway Thursday,
The drug giant said it was in talks to supply 35 countries with the new vaccine and had signed deals worth 979 millions US dollars (685.4 million euros) to supply the US government.
Experts had maintained that two doses of vaccine would be necessary to protect against the A(H1N1) infection, spreading existing supplies too thinly to provide widespread cover.
BASEL (Switzerland), Sept 3 (AFP): Swiss pharmaceutical giant Novatis said Thursday it had tested a new swine flu vaccine that may require only one dose while China also unveiled a one-dose drug designed to curb the pandemic.
Novatis said it was ready to produce one million doses of the vaccine before the end of the year in a bid to blunt the spread of swine flu that has already claimed at least 2,185 lives including its first victim in Norway Thursday,
The drug giant said it was in talks to supply 35 countries with the new vaccine and had signed deals worth 979 millions US dollars (685.4 million euros) to supply the US government.
Experts had maintained that two doses of vaccine would be necessary to protect against the A(H1N1) infection, spreading existing supplies too thinly to provide widespread cover.